Proteinuria: Significance, Evaluation, and Clinical Implications

Proteinuria (urinary protein excretion >150 mg/day) is a marker of kidney damage and an independent risk factor for CKD progression and cardiovascular disease.

Pathophysiology

  • Glomerular: Podocyte injury, GBM disruption, loss of charge/size selectivity (e.g., diabetic nephropathy, FSGS, membranous nephropathy).
  • Tubular: Impaired reabsorption of filtered low-MW proteins (e.g., interstitial nephritis, Fanconi syndrome).
  • Overflow: Excess serum low-MW proteins overwhelm tubular reabsorption (e.g., multiple myeloma – Bence Jones proteins).
  • Post-renal: UTI, inflammation, contamination (menstrual, seminal).

Evaluation

  • Urine dipstick: Semi-quantitative (trace to 4+); detects mainly albumin; false + with alkaline urine, concentrated urine; false – with dilute urine, non-albumin proteins.
  • Urine protein-to-creatinine ratio (UPCR): Spot urine; correlates with 24-hr excretion. >0.2 g/g abnormal; >3.5 g/g = nephrotic range.
  • Albumin-to-creatinine ratio (UACR): Preferred for diabetic CKD screening; ≥30 mg/g = microalbuminuria; ≥300 mg/g = macroalbuminuria.
  • 24-hr urine: Gold standard for quantification; cumbersome.
  • Urinalysis + microscopy: RBCs, casts, dysmorphic RBCs → glomerular origin.

Clinical Action

  • Confirm persistent proteinuria (repeat in 3 months).
  • Assess GFR (CKD-EPI), BP, cause-specific workup (serologies, complement, SPEP/UPEP, renal US).
  • Refer nephrology if: UPCR >1 g/g, GFR <60, hematuria, uncontrolled HTN, systemic disease.
  • ACEi/ARB first-line for proteinuric CKD (reduce proteinuria, slow progression).
  • SGLT2 inhibitors now standard for diabetic and non-diabetic proteinuric CKD.

Kidney Disease - Related Articles